Gene: PTBP3
Official Full Name: polypyrimidine tract binding protein 3provided by HGNC
Gene Summary: The protein encoded by this gene binds RNA and is a regulator of cell differentiation. The encoded protein preferentially binds to poly(G) and poly(U) sequences in vitro. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32410 | PTBP3 Knockout cell line (HeLa) | Human | PTBP3 | 1:3~1:6 | Negative | Online Inquiry |
KO32411 | PTBP3 Knockout cell line (HCT 116) | Human | PTBP3 | 1:2~1:4 | Negative | Online Inquiry |
KO32412 | PTBP3 Knockout cell line (HEK293) | Human | PTBP3 | 1:3~1:6 | Negative | Online Inquiry |
KO32413 | PTBP3 Knockout cell line (A549) | Human | PTBP3 | 1:3~1:4 | Negative | Online Inquiry |
PTBP3 Gene Knockout Cell Lines are a sophisticated set of genetically engineered cellular models designed specifically for the study of the polypyrimidine tract-binding protein 3 (PTBP3), a key regulator of pre-mRNA splicing. These cell lines utilize CRISPR-Cas9 technology for the precise knockout of the PTBP3 gene, resulting in cells that are invaluable tools for understanding the functional role of PTBP3 in RNA metabolism and gene regulation.
The primary function of PTBP3 is to facilitate the alternative splicing of pre-mRNA, a critical process that generates diverse protein isoforms from a single gene. By disrupting the PTBP3 gene, researchers can investigate the downstream effects on cellular processes, including differentiation, cell cycle regulation, and stress responses. These insights are particularly crucial in the context of diseases such as cancer, where dysregulated splicing patterns can contribute to tumorigenesis.
The scientific importance of PTBP3 Gene Knockout Cell Lines extends to their wide-ranging applications in both basic research and clinical settings. They serve as essential models for studying splicing mechanisms, validating therapeutic targets, and screening potential drug candidates aimed at modulating splicing events. Their utility is further amplified in pharmaceutical and biotechnology industries, where understanding splicing regulation is paramount for the development of RNA-based therapies.
What sets these knockout cell lines apart from alternatives is their high fidelity and efficiency, achieved through the precise genome editing capabilities of CRISPR technology. Researchers can rely on these models to produce reproducible results with well-characterized cellular responses, minimizing the variability often seen with traditional knockout methods.
For researchers and clinicians, the PTBP3 Gene Knockout Cell Lines represent a valuable asset in the quest to unravel the complexities of RNA biology. The detailed insights gained through the use of these cell lines can lead to breakthroughs in understanding disease mechanisms, ultimately facilitating advancements in therapeutic strategies.
Our company is dedicated to providing high-quality, innovative biological products backed by rigorous scientific research and expertise. With a commitment to supporting the scientific community, we deliver advanced solutions to help you achieve your research goals.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.